ATE484507T1 - Heterocyclische spiroverbindungen - Google Patents
Heterocyclische spiroverbindungenInfo
- Publication number
- ATE484507T1 ATE484507T1 AT08735533T AT08735533T ATE484507T1 AT E484507 T1 ATE484507 T1 AT E484507T1 AT 08735533 T AT08735533 T AT 08735533T AT 08735533 T AT08735533 T AT 08735533T AT E484507 T1 ATE484507 T1 AT E484507T1
- Authority
- AT
- Austria
- Prior art keywords
- spir
- heterocyclic
- compounds
- spir compounds
- heterocyclic spir
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/20—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Ophthalmology & Optometry (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07105246 | 2007-03-29 | ||
| PCT/EP2008/053671 WO2008119744A1 (en) | 2007-03-29 | 2008-03-27 | Heterocyclic spiro-compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE484507T1 true ATE484507T1 (de) | 2010-10-15 |
Family
ID=38461947
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT08735533T ATE484507T1 (de) | 2007-03-29 | 2008-03-27 | Heterocyclische spiroverbindungen |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US8324235B2 (de) |
| EP (1) | EP2134720B1 (de) |
| JP (1) | JP5331789B2 (de) |
| KR (1) | KR20090126310A (de) |
| CN (1) | CN101711252A (de) |
| AR (1) | AR066691A1 (de) |
| AT (1) | ATE484507T1 (de) |
| AU (1) | AU2008234957A1 (de) |
| BR (1) | BRPI0809645A2 (de) |
| CA (1) | CA2681978A1 (de) |
| DE (1) | DE602008003015D1 (de) |
| ES (1) | ES2354008T3 (de) |
| MX (1) | MX2009008264A (de) |
| PL (1) | PL2134720T3 (de) |
| PT (1) | PT2134720E (de) |
| RU (1) | RU2009139811A (de) |
| TW (1) | TW200904416A (de) |
| WO (1) | WO2008119744A1 (de) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2009151069A1 (ja) | 2008-06-12 | 2011-11-17 | 第一三共株式会社 | 4,7−ジアザスピロ[2.5]オクタン環構造を有するイミダゾチアゾール誘導体 |
| PL2435409T3 (pl) | 2009-05-28 | 2015-01-30 | Novartis Ag | Podstawione pochodne aminopropionowe jako inhibitory neprylizyny |
| CA2763565A1 (en) | 2009-05-28 | 2010-12-02 | Novartis Ag | Substituted aminobutyric derivatives as neprilysin inhibitors |
| IN2012DN00549A (de) * | 2009-07-15 | 2015-06-12 | Zhejiang Beta Pharma Inc | |
| JO2967B1 (en) | 2009-11-20 | 2016-03-15 | نوفارتس ايه جي | Acetic acid derivatives of carbamoyl methyl amino are substituted as new NEP inhibitors |
| US8877815B2 (en) | 2010-11-16 | 2014-11-04 | Novartis Ag | Substituted carbamoylcycloalkyl acetic acid derivatives as NEP |
| US8673974B2 (en) | 2010-11-16 | 2014-03-18 | Novartis Ag | Substituted amino bisphenyl pentanoic acid derivatives as NEP inhibitors |
| CN103648495A (zh) | 2011-07-08 | 2014-03-19 | 诺华股份有限公司 | 在高甘油三酯对象中治疗动脉粥样硬化的方法 |
| EP2567959B1 (de) | 2011-09-12 | 2014-04-16 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridin-4-carbonsäureamid-derivate als kinaseinhibitoren |
| UY35144A (es) | 2012-11-20 | 2014-06-30 | Novartis Ag | Miméticos lineales sintéticos de apelina para el tratamiento de insuficiencia cardiaca |
| SG11201506018PA (en) | 2013-02-14 | 2015-08-28 | Novartis Ag | Substituted bisphenyl butanoic phosphonic acid derivatives as nep (neutral endopeptidase) inhibitors |
| EP3024845A1 (de) | 2013-07-25 | 2016-06-01 | Novartis AG | Cyclische polypeptide zur behandlung von herzinsuffizienz |
| WO2015013169A2 (en) | 2013-07-25 | 2015-01-29 | Novartis Ag | Bioconjugates of synthetic apelin polypeptides |
| SG11201704758XA (en) | 2015-01-23 | 2017-08-30 | Novartis Ag | Synthetic apelin fatty acid conjugates with improved half-life |
| JPWO2017213247A1 (ja) * | 2016-06-10 | 2019-04-04 | 日本メジフィジックス株式会社 | 心疾患の非侵襲的画像診断剤 |
| JOP20190086A1 (ar) | 2016-10-21 | 2019-04-18 | Novartis Ag | مشتقات نافثيريدينون جديدة واستخدامها في معالجة عدم انتظام ضربات القلب |
| EP3658129A4 (de) * | 2017-07-25 | 2021-08-25 | The Board of Trustees of the Leland Stanford Junior University | Glucose-6-phosphat-dehydrogenase (g6pd)modulierende mittel und verfahren zur behandlung von g6pd-mangel |
| UY38072A (es) | 2018-02-07 | 2019-10-01 | Novartis Ag | Compuestos derivados de éster butanoico sustituido con bisfenilo como inhibidores de nep, composiciones y combinaciones de los mismos |
| WO2020110008A1 (en) | 2018-11-27 | 2020-06-04 | Novartis Ag | Cyclic pentamer compounds as proprotein convertase subtilisin/kexin type 9 (pcsk9) inhibitors for the treatment of metabolic disorder |
| JP7657151B2 (ja) | 2018-11-27 | 2025-04-04 | ノバルティス アーゲー | 代謝性障害の処置のためのプロタンパク質コンバターゼスブチリシン/ケキシン9型(pcsk9)阻害剤としての環状ペプチド |
| UY38485A (es) | 2018-11-27 | 2020-06-30 | Novartis Ag | Compuestos tetrámeros cíclicos como inhibidores de proproteína convertasa subtilisina/kexina tipo 9 (pcsk9), método de tratamiento, uso y su preparación |
| WO2023084449A1 (en) | 2021-11-12 | 2023-05-19 | Novartis Ag | Diaminocyclopentylpyridine derivatives for the treatment of a disease or disorder |
| AR127698A1 (es) | 2021-11-23 | 2024-02-21 | Novartis Ag | Derivados de naftiridinona para el tratamiento de una enfermedad o un trastorno |
| IL324432A (en) | 2023-05-24 | 2026-01-01 | Novartis Ag | Naphthyridinone derivatives for the treatment of a disease or disorder |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200716634A (en) * | 2005-05-31 | 2007-05-01 | Speedel Experimenta Ag | Heterocyclic spiro-compounds |
| TW200716636A (en) * | 2005-05-31 | 2007-05-01 | Speedel Experimenta Ag | Heterocyclic spiro-compounds |
-
2008
- 2008-03-27 AR ARP080101259A patent/AR066691A1/es unknown
- 2008-03-27 TW TW097110903A patent/TW200904416A/zh unknown
- 2008-03-27 WO PCT/EP2008/053671 patent/WO2008119744A1/en not_active Ceased
- 2008-03-27 AU AU2008234957A patent/AU2008234957A1/en not_active Abandoned
- 2008-03-27 ES ES08735533T patent/ES2354008T3/es active Active
- 2008-03-27 RU RU2009139811/04A patent/RU2009139811A/ru not_active Application Discontinuation
- 2008-03-27 PL PL08735533T patent/PL2134720T3/pl unknown
- 2008-03-27 PT PT08735533T patent/PT2134720E/pt unknown
- 2008-03-27 MX MX2009008264A patent/MX2009008264A/es active IP Right Grant
- 2008-03-27 CA CA002681978A patent/CA2681978A1/en not_active Abandoned
- 2008-03-27 KR KR1020097022483A patent/KR20090126310A/ko not_active Withdrawn
- 2008-03-27 DE DE602008003015T patent/DE602008003015D1/de active Active
- 2008-03-27 AT AT08735533T patent/ATE484507T1/de active
- 2008-03-27 JP JP2010500283A patent/JP5331789B2/ja not_active Expired - Fee Related
- 2008-03-27 US US12/450,521 patent/US8324235B2/en not_active Expired - Fee Related
- 2008-03-27 CN CN200880010854A patent/CN101711252A/zh active Pending
- 2008-03-27 EP EP08735533A patent/EP2134720B1/de not_active Not-in-force
- 2008-03-27 BR BRPI0809645-7A patent/BRPI0809645A2/pt not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| MX2009008264A (es) | 2009-08-12 |
| EP2134720A1 (de) | 2009-12-23 |
| KR20090126310A (ko) | 2009-12-08 |
| PT2134720E (pt) | 2010-12-07 |
| CA2681978A1 (en) | 2008-10-09 |
| WO2008119744A1 (en) | 2008-10-09 |
| JP2010522725A (ja) | 2010-07-08 |
| CN101711252A (zh) | 2010-05-19 |
| US8324235B2 (en) | 2012-12-04 |
| DE602008003015D1 (de) | 2010-11-25 |
| ES2354008T3 (es) | 2011-03-09 |
| US20100144774A1 (en) | 2010-06-10 |
| AR066691A1 (es) | 2009-09-09 |
| TW200904416A (en) | 2009-02-01 |
| RU2009139811A (ru) | 2011-05-10 |
| JP5331789B2 (ja) | 2013-10-30 |
| BRPI0809645A2 (pt) | 2014-09-23 |
| PL2134720T3 (pl) | 2011-04-29 |
| AU2008234957A1 (en) | 2008-10-09 |
| EP2134720B1 (de) | 2010-10-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602008003015D1 (de) | Heterocyclische spiroverbindungen | |
| ATE502948T1 (de) | Substituierte bicyclolactamverbindungen | |
| BRPI0916233A2 (pt) | compostos heterocíclicos antivirais | |
| BRPI0813500A2 (pt) | Compostos antivirais | |
| BRPI0821086A2 (pt) | Compostos inseticidas | |
| BRPI0906705A2 (pt) | Composto heterocíclicos | |
| BRPI0815042A2 (pt) | Compostos de pirazol | |
| BRPI0811280A2 (pt) | Compostos amino-heterocíclicos | |
| DK2240490T3 (da) | Organiske forbindelser | |
| BRPI0817434A2 (pt) | Composto orgânicos | |
| BRPI0718509A2 (pt) | compostos orgânicos heterocíclicos | |
| BRPI0811562A2 (pt) | Compostos orgânicos | |
| EP2170350A4 (de) | Substituierte imidazoheterocyclen | |
| ATE542825T1 (de) | Substituierte piperidino-dihydrothienopyrimidine | |
| BRPI0821349A2 (pt) | compostos antivirais heterocíclicos | |
| BRPI0811264A2 (pt) | Compostos | |
| BRPI0809996A2 (pt) | Compostos | |
| BRPI0814424A2 (pt) | Compostos heterociclila | |
| EP2210876A4 (de) | Heterocyclische verbindung | |
| BRPI0821401A2 (pt) | Compostos orgânicos | |
| BRPI0924121A2 (pt) | compostos antivirais heterocíclicos | |
| BRPI0818005A2 (pt) | Compostos orgânicos | |
| HRP20150932T1 (xx) | Heterocikliäśki spojevi | |
| BRPI0817149A2 (pt) | Cartucho de tinta | |
| BRPI0816512A2 (pt) | Cartucho de tinta |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 2134720 Country of ref document: EP |